Director Wayne A.I. Frederick filed a Form 4 with the SEC on November 12, 2026, disclosing a sale of 440 shares of Humana Inc. common stock on November 10, 2026, and reporting his resulting beneficial ownership position.
Key Highlights
- Sale transaction: 440 shares of Humana Common disposed of on November 10, 2026, at a price of $440.575 per share.
- Post-transaction direct ownership: 0 shares of Humana Common held directly following the reported sale.
- Deferred stock units (annual director fee): 3,174 restricted stock units remain held directly, including 766 units representing a contingent right to receive one share of Humana Inc. common stock.
- Deferred dividend stock units: 73 restricted stock units held directly, representing reinvested director dividend payments on vested and deferred stock units.
- Relationship to issuer: Reporting person is identified as a Director of Humana Inc., listed on NYSE:HUM.
Frederick's November 2026 Share Sale and Deferred Unit Holdings at Humana
According to the filing, Wayne A.I. Frederick, identified as a director of Humana Inc. (NYSE:HUM), sold 440 shares of Humana Common on November 10, 2026, at a reported price of $440.575 per share, with all shares sold at that reported price. Following the transaction, the filing reports that Frederick's direct beneficial ownership of Humana Common stock stands at 0 shares.
In addition to the common stock position, the filing discloses two categories of derivative securities held by Frederick. The first consists of 3,174 restricted stock units described as an "Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director," at which time the units will be payable in Humana Inc. common stock on a 1-for-1 basis. The filing notes these are "exempt pursuant to Rule 16(b)-3(d)(I)" and that the total includes 766 restricted stock units representing a "contingent right to receive one share of Humana Inc. common stock" under the Company's 2019 Amended and Restated Plan.
The second category consists of 73 restricted stock units described as a "Director's dividend payment reinvested into stock units on vested and deferred stock units," also deferred until resignation of director services, at which time they will be payable in Humana Inc. common stock on a 1-for-1 basis. Both derivative positions are reported as directly held. The filing was signed by Wayne A.I. Frederick and dated November 12, 2026.
What Was Disclosed
The filing reports a sale of 440 Humana Common shares at $440.575 on November 10, 2026, leaving zero direct common shares. It also discloses 3,174 and 73 deferred restricted stock units held as derivative securities.






Please wait processing your request...